These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17706552)

  • 1. A first therapy for Niemann-Pick C.
    Erickson RP
    Lancet Neurol; 2007 Sep; 6(9):748-9. PubMed ID: 17706552
    [No Abstract]   [Full Text] [Related]  

  • 2. Early miglustat therapy in infantile Niemann-Pick disease type C.
    Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
    Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult form of Niemann-Pick type C with the variant biochemical phenotype on treatment with Miglustat.
    Jesús S; Cáceres-Redondo MT; Carrillo F; Cordones I; Escudero M; Macías-Vidal J; Coll MJ; Bautista J; Mir P
    Parkinsonism Relat Disord; 2013 Oct; 19(10):916-7. PubMed ID: 23791518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Niemann-Pick diseases in adults].
    Sedel F
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S292-3. PubMed ID: 17961863
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Annexins in Niemann-Pick type C disease].
    Buszewska ME; Strzelecka-Kiliszek A; Tylki-Szymańska A; Bandorowicz-Pikuła J
    Postepy Biochem; 2007; 53(2):169-73. PubMed ID: 17969878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motion analysis of a child with Niemann-Pick disease type C treated with miglustat.
    Paciorkowski AR; Westwell M; Ounpuu S; Bell K; Kagan J; Mazzarella C; Greenstein RM
    Mov Disord; 2008 Jan; 23(1):124-8. PubMed ID: 17973331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Niemann-Pick type C disease. Rare but possible diagnosis in adult neurology and psychiatry].
    Mattsson N; Månsson JE; Blomqvist M; Campbell E
    Lakartidningen; 2013 May 7-21; 110(19-20):956-7. PubMed ID: 23745504
    [No Abstract]   [Full Text] [Related]  

  • 9. Spreading the wealth: Niemann-Pick type C proteins bind and transport cholesterol.
    Munkacsi AB; Pentchev PG; Sturley SL
    Cell Metab; 2009 Jul; 10(1):3-4. PubMed ID: 19583946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Niemann-Pick disease--a rare disease in children's hepatology (a clinical case)].
    Berezenko VS; Dyba MB
    Eksp Klin Gastroenterol; 2014; (8):101-5. PubMed ID: 25911921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.
    Lloyd-Evans E; Platt FM
    Traffic; 2010 Apr; 11(4):419-28. PubMed ID: 20059748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
    Pérez-Poyato MS; Gordo MM; Marfa MP
    Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPC1 defect results in abnormal platelet formation and function: studies in Niemann-Pick disease type C1 patients and zebrafish.
    Louwette S; Régal L; Wittevrongel C; Thys C; Vandeweeghde G; Decuyper E; Leemans P; De Vos R; Van Geet C; Jaeken J; Freson K
    Hum Mol Genet; 2013 Jan; 22(1):61-73. PubMed ID: 23010472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term miglustat therapy in children with Niemann-Pick disease type C.
    Patterson MC; Vecchio D; Jacklin E; Abel L; Chadha-Boreham H; Luzy C; Giorgino R; Wraith JE
    J Child Neurol; 2010 Mar; 25(3):300-5. PubMed ID: 19822772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of plasma membrane-derived cholesterol and the function of Niemann-Pick C1 Protein.
    Wiegand V; Chang TY; Strauss JF; Fahrenholz F; Gimpl G
    FASEB J; 2003 Apr; 17(6):782-4. PubMed ID: 12594172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guilty until proven innocent: the case of NPC1 and cholesterol.
    Ioannou YA
    Trends Biochem Sci; 2005 Sep; 30(9):498-505. PubMed ID: 16054367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Niemann-Pick C disease: history, current research topics, biological and molecular diagnosis].
    Vanier MT
    Arch Pediatr; 2010 Jun; 17 Suppl 2():S41-4. PubMed ID: 20620894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niemann-Pick type C: a potentially treatable disorder?
    Kheder A; Scott C; Olpin S; Hadjivassiliou M
    Pract Neurol; 2013 Dec; 13(6):382-5. PubMed ID: 23906593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological and clinical profiles of miglustat (Brazaves(®)) for the treatment of Niemann-Pick type C disease].
    Kitatani T; Takahashi S; Ikenoya S
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):160-7. PubMed ID: 23470482
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.
    Karimzadeh P; Tonekaboni SH; Ashrafi MR; Shafeghati Y; Rezayi A; Salehpour S; Ghofrani M; Taghdiri MM; Rahmanifar A; Zaman T; Aryani O; Shoar BN; Shiva F; Tavasoli A; Houshmand M
    J Child Neurol; 2013 Dec; 28(12):1599-606. PubMed ID: 23143717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.